Cascades (TSE:CAS – Get Free Report) was upgraded by research analysts at Scotiabank from a “hold” rating to a “strong-buy” rating in a report issued on Monday,Zacks.com reports.
Several other equities research analysts have also recently weighed in on CAS. Royal Bank of Canada upped their price target on Cascades from C$12.00 to C$13.00 and gave the stock a “sector perform” rating in a research note on Friday, December 20th. TD Securities upped their target price on shares of Cascades from C$12.00 to C$14.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. Finally, CIBC lifted their price target on shares of Cascades from C$12.00 to C$13.00 in a research report on Wednesday, January 15th. Four investment analysts have rated the stock with a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of C$12.50.
Check Out Our Latest Stock Analysis on Cascades
Cascades Stock Up 0.6 %
Cascades (TSE:CAS – Get Free Report) last released its quarterly earnings results on Thursday, November 7th. The company reported C$0.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of C$0.14 by C$0.13. Cascades had a negative net margin of 0.91% and a negative return on equity of 1.44%. During the same period in the prior year, the company earned $0.44 earnings per share. Equities analysts expect that Cascades will post 1.2959309 earnings per share for the current year.
Insiders Place Their Bets
In other news, Senior Officer Luc Langevin sold 3,000 shares of the stock in a transaction that occurred on Tuesday, November 12th. The shares were sold at an average price of C$11.30, for a total transaction of C$33,900.00. Corporate insiders own 23.78% of the company’s stock.
Cascades Company Profile
Cascades Inc produces, converts, and markets packaging and tissue products in Canada and the United States. The company operates through three segments: Containerboard, Specialty Products, and Tissue Papers. It offers various packaging solutions and tissue products comprised of recycled fibers; tissue papers, comprising parent rolls of virgin and recycled fibres; specialty products, including uncoated recycled boxboards; and containerboards.
Further Reading
- Five stocks we like better than Cascades
- Upcoming IPO Stock Lockup Period, Explained
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- High Flyers: 3 Natural Gas Stocks for March 2022
- What Does the Future Hold for Eli Lilly?
- Basic Materials Stocks Investing
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Cascades Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cascades and related companies with MarketBeat.com's FREE daily email newsletter.